SARA MCGOWAN: Open Payments
NPI 1699047969 · MASSAPEQUA PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,696 in 62 payments from 11 companies in 2025. Trend: 2023 $172 · 2024 $1,110 · 2025 $1,696
Food & beverage: $1,696
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $425 |
| Otsuka America Pharmaceutical, Inc. | 12 | $279 |
| Braeburn Inc. | 6 | $248 |
| Neurocrine BioSciences, Inc. | 7 | $202 |
| ABBVIE INC. | 9 | $155 |
| Alkermes, Inc. | 4 | $112 |
| Indivior Inc. | 4 | $104 |
| Janssen Pharmaceuticals, Inc | 2 | $75 |
| Lundbeck LLC | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: CAPLYTA, BRIXADI, INGREZZA, REXULTI, MAVYRET, ABILIFY ASIMTUFII, SUBLOCADE, VIVITROL.
Industry payments across NY — which companies pay providers there.
